Patent · US Active

3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives

US10179777B2 · kind B2 · utility

2Cited by

5References

17Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Dieter Dorsch · Ober-Ramstadt, DE
Alfred Jonczyk · Darmstadt, DE
Mireille Krier · Mühltal, DE

Key dates

Filing date	Mar 22, 2016
Grant date	Jan 15, 2019
Priority date	—
Expiry date	Mar 22, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula I in which W, R1, R2 and R3 have the meanings indicated in claim 1, are inhibitors of ALK1, AL2 and ALK5, and can be employed for the treatment of diseases such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.